4//SEC Filing
Robinson Byron 4
Accession 0001209191-23-001885
CIK 0001817713other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 4:35 PM ET
Size
5.4 KB
Accession
0001209191-23-001885
Insider Transaction Report
Form 4
Robinson Byron
Chief Strategy Officer
Transactions
- Award
Stock Option (right to buy)
2023-01-03+100,000→ 100,000 totalExercise: $14.02Exp: 2033-01-02→ Common Stock (100,000 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option vest on January 1, 2024 and the balance will vest in equal monthly installments thereafter over a three year period.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0001914899
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 4:35 PM ET
- Size
- 5.4 KB